Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
19.50
-0.26 (-1.32%)
Feb 24, 2025, 12:07 PM EST - Market open
Sionna Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 12.09 | 9.71 | 6.77 |
| Research & Development | 52.93 | 40.63 | 34.61 |
| Operating Expenses | 65.02 | 50.33 | 41.37 |
| Operating Income | -65.02 | -50.33 | -41.37 |
| Interest & Investment Income | 6.6 | 2.77 | 1.13 |
| Other Non Operating Income (Expenses) | 0.7 | 0.3 | - |
| Pretax Income | -57.72 | -47.26 | -40.24 |
| Net Income | -57.72 | -47.26 | -40.24 |
| Net Income to Common | -57.72 | -47.26 | -40.24 |
| Shares Outstanding (Basic) | 3 | 3 | 3 |
| Shares Outstanding (Diluted) | 3 | 3 | 3 |
| Shares Change (YoY) | - | 13.80% | - |
| EPS (Basic) | -16.77 | -16.11 | -15.61 |
| EPS (Diluted) | -16.77 | -16.11 | -15.61 |
| Free Cash Flow | -48.58 | -44.82 | -37.94 |
| Free Cash Flow Per Share | -14.11 | -15.28 | -14.72 |
| EBITDA | -64.36 | -49.75 | -41.25 |
| D&A For EBITDA | 0.66 | 0.58 | 0.12 |
| EBIT | -65.02 | -50.33 | -41.37 |
Source: S&P Capital IQ. Standard template.
Financial Sources.